Insight Molecular Diagnostics Inc. Income (Loss) from Equity Method Investments
Insight Molecular Diagnostics Inc. (IMDX) reported Income (Loss) from Equity Method Investments of -$270.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-04-12.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2023-04-12
- Insight Molecular Diagnostics Inc. income (loss) from equity method investments for the quarter ending 2021-12-31 was $0.00.
- Insight Molecular Diagnostics Inc. income (loss) from equity method investments for the quarter ending 2021-09-30 was $0.00.
- Insight Molecular Diagnostics Inc. income (loss) from equity method investments for the quarter ending 2021-06-30 was $0.00.
- Insight Molecular Diagnostics Inc. income (loss) from equity method investments for the quarter ending 2021-03-31 was -$270.00K.
- Insight Molecular Diagnostics Inc. income (loss) from equity method investments for fiscal 2021 was -$270.00K.
- Insight Molecular Diagnostics Inc. income (loss) from equity method investments for fiscal 2020 was -$1.55M.
- Insight Molecular Diagnostics Inc. income (loss) from equity method investments for fiscal 2019 was -$281.00K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $0.00 derived: sum of 2 quarters · filed 2023-04-12 | $0.00 derived: sum of 3 quarters · filed 2023-04-12 | -$270.00K 10-K · filed 2023-04-12 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | -$270.00K 10-Q · filed 2022-11-10 | -$705.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$270.00K 10-Q · filed 2022-08-12 | -$705.00K derived: sum of 3 quarters · filed 2022-08-12 | -$1.19M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$270.00K 10-Q · filed 2022-05-12 | -$705.00K derived: sum of 2 quarters · filed 2022-05-12 | -$1.19M derived: sum of 3 quarters · filed 2022-05-12 | -$1.49M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$435.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$917.00K derived: sum of 2 quarters · filed 2022-03-11 | -$1.22M derived: sum of 3 quarters · filed 2022-03-11 | -$1.55M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$482.00K 10-Q · filed 2021-11-09 | -$783.00K derived: sum of 2 quarters · filed 2021-11-09 | -$1.11M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$301.00K 10-Q · filed 2021-08-11 | -$630.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$329.00K 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | -$281.00K 10-K · filed 2021-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |